Printer Friendly

MICHEL DE ROSEN APPOINTED MEMBER OF RHONE-POULENC'S EXECUTIVE COMMITTEE

MICHEL DE ROSEN APPOINTED MEMBER OF RHONE-POULENC'S EXECUTIVE COMMITTEE
 PRINCETON, N.J., May 20 /PRNewswire/ -- Michel de Rosen, president of Rhone-Poulenc's Fibres and Polymers sector since 1990, has been appointed a member of the group's executive committee, effective June 1.
 He joins Jean-Rene Fourtou, Jean-Marc Bruel, Philippe Desmarescaux, Igor Landau, Edson vaz Musa and Jean-Pierre Tirouflet.
 De Rosen, age 41, inspector of finance, graduated from H.E.C. and is an ex-pupil of the "Ecole Nationale d'Administration." He joined the Rhone-Poulenc Group in 1982 as deputy to the president of Rhone-Poulenc's Health sector, and was promoted to president of Pharmuka (Rhone-Poulenc Group), in 1984.
 Between 1986-1988, he was director of staff for the Minister of Industry, Post, Telecommunications and Tourism, before being appointed president of Rhone-Poulenc's Fibres sector.
 /delval/
 -0- 5/20/92
 /CONTACT: Ronald R. Gurczynski of Rhone-Poulenc, 908-821-3446/
 (RPU) CO: Rhone-Poulenc, Inc. ST: New Jersey IN: MTC SU: PER


JS-MK -- PH007 -- 2243 05/20/92 10:12 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:May 20, 1992
Words:160
Previous Article:DETROIT EDISON TO REDEEM $2.75 SERIES PREFERENCE STOCK
Next Article:ICI AND DU PONT AGREE ON NYLON AND ACRYLICS BUSINESS TRANSACTIONS
Topics:


Related Articles
RHONE-POULENC, ETHYL SIGN LETTER OF INTENT
NEW ALLOCATION OF RESPONSIBILITIES WITHIN RHONE-POULENC'S EXECUTIVE COMMITTEE
SALES OF SHARES IN RHONE-POULENC HELD BY THE STATE
ROBERT BOZZA APPOINTED VICE PRESIDENT OF ACREON CATALYSTS
RHONE-POULENC FORMS NEW CHEMICAL SECTOR
DWIGHT GRIMESTAD NAMED INVESTOR RELATIONS DIRECTOR FOR RHONE-POULENC INC.
Launch Of Tender Offer by Rhone-Poulenc For Shares of Rhone-Poulenc Rorer: Agreement Reached on $97 Per Share
Patrick Langlois Appointed To Rhone-Poulenc's Executive Committee
Aventis Pharma to Locate Global Drug Development Center, North America Headquarters in New Jersey Following Merger of Rhone-Poulenc Rorer And Hoechst...
Aventis, New World Leader in Life Sciences, Launched Today.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters